Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Internal Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Bezafibrate may prevent or delay type 2 diabetes

NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes, according to results of a retrospective study reported in the April issue of...

Reuters Health • The Doctor's Channel Daily Newscast

Calcium may help prevent hyperoxaluric kidney stones

NEW YORK (Reuters Health) – By binding dietary oxalate, calcium supplements or calcium-containing foods may be useful in the management of hyperoxaluria, new research suggests. Hyperoxaluria is present in roughly 20 percent of patients with calcium...
Rasheed A. Balogun, MD, Associate Professor of Medicine in the Division of Nephrology at the University of Virginia Health System, discusses the risk factors for Chronic Kidney Disease including hypertension and diabetes. References and Resources ...